Assyro AI

Orange Book product · Brand (NDA)

PHEXX

CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE

Brand (NDA)NDA 208352RX EVOFEM INC

At a glance

May 22, 2020

Approved

Brand (NDA)

Application

Not listed

TE code

4

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 22, 2020

    6 yr 2 mo ago

  2. Today

  3. Patent 10568855 expires

    Listed method-of-use patent (U-1) expiration.

    Mar 15, 2033

    in 6 yr 10 mo

  4. Patent 11337989 expires

    Listed method-of-use patent (U-1) expiration.

    Mar 15, 2033

    in 6 yr 10 mo

  5. Patent 11439610 expires

    Listed drug substance patent expiration.

    Mar 15, 2033

    in 6 yr 10 mo

  6. Patent 11992472 expires

    Listed method-of-use patent (U-1) expiration.

    Mar 15, 2033

    in 6 yr 10 mo

Pharmaceutical detail

Active ingredient

CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE

Strength

1%;1.8%;0.4%

Dosage form

GEL

Route

VAGINAL

TE code

Not listed

Application

NDA 208352

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (4)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10568855Mar 15, 2033in 6 yr 10 mo
U-1
11337989Mar 15, 2033in 6 yr 10 mo
U-1
11439610Mar 15, 2033in 6 yr 10 mo
SubstanceProduct
11992472Mar 15, 2033in 6 yr 10 mo
U-1
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.